Equine Sarcoid Management: Balancing Welfare and Practicality

Sarcoids are the most common skin tumors in horses, requiring individualized management decisions based on location, size, and welfare impact.

Key Facts

Sarcoids are caused by bovine papillomavirus and occur in all equid species
They occur in six forms: flat, verrucose, nodular, fibroblastic, mixed, and occult
Treatment options include banding, topical chemotherapy (Liverpool cream, AW5), cryotherapy, electrochemotherapy, and intralesional cisplatin
Surgery alone has high recurrence rates (50-60%) - adjunctive treatment is usually needed
Sarcoids near the eye, girth area, or mouth require treatment due to functional impact
Some occult or verrucose sarcoids can be monitored without treatment if not growing or causing problems
Stress and immune compromise may stimulate sarcoid growth

Welfare Considerations

Many sarcoids cause minimal welfare impact and can be monitored without intervention. The welfare concern arises when sarcoids interfere with tack, locomotion, or vision, causing chronic discomfort or preventing normal function. Treatment decisions should weigh the welfare cost of the sarcoid against the welfare cost of treatment - some treatments cause significant local discomfort and tissue reaction. For progressive or functionally impactful sarcoids, early treatment while lesions are small generally produces better welfare outcomes than waiting.

What You Can Do

Photograph and document sarcoids at least twice yearly to track changes in size and number
Seek veterinary assessment for any rapidly growing sarcoid or those near functional areas
Discuss treatment options with a vet experienced in equine sarcoid management
Avoid biopsy of suspicious sarcoids - trauma can stimulate aggressive growth
Consider specialist referral (electrochemotherapy, cisplatin) for challenging or recurrent cases